Cure8 research brief
The paper describes a new immunometabolic mechanism that strengthened intestinal barrier function and reduced colitis in mice, suggesting a potential pathway to develop therapies that boost ILC3-driven IL-22 production for ulcerative colitis.
Researchers studying IBD immunology, immunometabolism, and drug discovery; clinicians interested in emerging mechanistic research on barrier-protective strategies for UC.
The study is preclinical (mouse models and cellular/organoid work) and identifies rhoifolin as a compound that increases NAD+ via direct interaction with NMNAT1, activates SIRT1, and promotes FOXO1-mediated IL-22 transcription in group 3 innate lymphoid cells (ILC3s).
The authors used transcriptomics and metabolomics to link nicotinamide salvage metabolism to enhanced ILC3 effector function and showed molecular docking and mutation data supporting NMNAT1 as a target. The findings are mechanistic and exploratory rather than clinical.
Rhoifolin improved disease measures in DSS and TNBS mouse colitis models and enhanced barrier protection in colonic epithelial cells and organoids, but human safety, dosing, and efficacy were not assessed here.
Preclinical mouse and cellular/organoid experiments identify mechanisms and a candidate compound (rhoifolin). The study does not include human clinical data; translational steps and safety testing are still needed.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study identifies a plant-derived compound (poricoic acid A) that reduced inflammation, cellular senescence, and colon injury in cell and mouse models of ulcerative colitis and links those effects to AMPK/PPARγ...
This study identifies a plant-derived compound that reduced inflammation and promoted intestinal healing in mouse models by modulating the Wnt/β-catenin pathway and ILC3-driven IL-22 production—pathways relevant to...
The study links a traditional herbal formula to improved colitis in mice and to changes in bile-acid metabolism through the FXR–FGF15 pathway, suggesting a mechanistic route that could inform future preclinical or...
